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Identification of a major IP5 kinase 
in Cryptococcus neoformans 
confirms that PP-IP5/IP7, not IP6,  
is essential for virulence
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Fungal inositol polyphosphate (IP) kinases catalyse phosphorylation of IP3 to inositol pyrophosphate, 
PP-IP5/IP7, which is essential for virulence of Cryptococcus neoformans. Cryptococcal Kcs1 converts 
IP6 to PP-IP5/IP7, but the kinase converting IP5 to IP6 is unknown. Deletion of a putative IP5 kinase-
encoding gene (IPK1) alone (ipk1Δ), and in combination with KCS1 (ipk1Δkcs1Δ), profoundly reduced 
virulence in mice. However, deletion of KCS1 and IPK1 had a greater impact on virulence attenuation 
than that of IPK1 alone. ipk1Δkcs1Δ and kcs1Δ lung burdens were also lower than those of ipk1Δ. Unlike 
ipk1Δ, ipk1Δkcs1Δ and kcs1Δ failed to disseminate to the brain. IP profiling confirmed Ipk1 as the 
major IP5 kinase in C. neoformans: ipk1Δ produced no IP6 or PP-IP5/IP7 and, in contrast to ipk1Δkcs1Δ, 
accumulated IP5 and its pyrophosphorylated PP-IP4 derivative. Kcs1 is therefore a dual specificity (IP5 
and IP6) kinase producing PP-IP4 and PP-IP5/IP7. All mutants were similarly attenuated in virulence 
phenotypes including laccase, urease and growth under oxidative/nitrosative stress. Alternative carbon 
source utilisation was also reduced significantly in all mutants except ipk1Δ, suggesting that PP-IP4 
partially compensates for absent PP-IP5/IP7 in ipk1Δ grown under this condition. In conclusion, PP-IP5/
IP7, not IP6, is essential for fungal virulence.
The fungal pathogen, Cryptococcus neoformans, predominantly infects immunocompromised individuals via the 
lung and then disseminates to the brain where it establishes life-threatening meningoencephalitis. C. neoformans 
is responsible for over half a million deaths each year in AIDS patients alone1. Some of the most well-known 
virulence factors of C. neoformans include a polysaccharide capsule2, melanin3 and urease4,5. A prerequisite to vir-
ulence is its ability to grow at human physiological temperature, which can impact the stability of the cell wall6,7. 
In the host, C. neoformans also encounters oxidative and nitrosative stress, which originate predominantly from 
macrophages and altered nutritional availability in the lung and brain, which are low in glucose8–13.
Several signalling cascades, including calcineurin, mitogen-activated protein kinase/protein kinase C (Mpk1/
Pkc1), cyclic adenosine monophosphate/protein kinase A (cAMP/Pka1), high osmolarity glycerol (HOG), and 
Rim101 pathways, allow C. neoformans to sense, respond and adapt to host stresses encountered throughout the 
course of infection14–20. We previously identified a new virulence-related signalling pathway in C. neoformans 
comprising phospholipase C1 (Plc1) and a series of sequentially acting inositol polyphosphate kinases (IPKs)21–23. 
The IPKs convert the inositol trisphosphate (IP3) product of Plc1 to IP4-IP6, and IP6 to the inositol pyrophos-
phates, PP-IP5/IP7 and (PP)2-IP4/IP8. Specifically, IP3 is converted to IP4 and IP5 by Arg122,23. An uncharacterised 
kinase then phosphorylates IP5 to produce the highly abundant IP6 species. IP6 is then phosphorylated by Kcs1 to 
PP-IP5/IP7. Asp1 further phosphorylates PP-IP5/IP7 to produce (PP)2-IP4/IP823. ARG1 and KCS1 deletion mutants 
of C. neoformans, which do not produce PP-IP5/IP7 and (PP)2-IP4/IP8, exhibit attenuated growth, compromised 
cell wall integrity and reduced production of melanin, urease and mating filaments. The KCS1 deletion strain, 
kcs1Δ, is also unable to utilise alternative carbon sources for growth23. Consequently kcs1Δ has a reduced ability 
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to infect host lung, does not disseminate to the brain and is avirulent in a mouse model23. However, (PP)2-IP4/
IP8 plays an insignificant role in cryptococcal virulence per se, since the IP8-deficient mutant strain, asp1Δ, had a 
similar virulence profile to that of the wild-type strain23. Our results therefore support a crucial role for PP-IP5/
IP7 in the pathogenicity of C. neoformans23. While IP6 is the precursor for the synthesis of virulence-promoting 
PP-IP5/IP7 in C. neoformans, neither the IP5 kinase responsible for production of IP6, nor the contribution of IP6 
to fungal pathogenicity is currently known.
In this study we employ combinatorial gene deletion analysis, HPLC-based inositol polyphosphate profiling, 
phenotypic analysis and a mouse infection model to establish Ipk1 as the major IP5 kinase in C. neoformans, and 
assess the contribution of the Ipk1 product, IP6, to pathogenicity. Similar to Kcs1 we found that Ipk1 is essential 
for pathogenicity but that its contribution relates more to its indirect role in PP-IP5/IP7 production, rather than 
its direct role in producing IP6. Our results therefore confirm that PP-IP5/IP7 is the most crucial IP species for 
cryptococcal pathogenicity and that the contribution of IP6 is relatively insignificant.
Results
Identification of an IP5 kinase in C. neoformans. Homology search. We recently identified Arg1 as 
the major IP3 kinase in C. neoformans (Cn) converting Plc1-derived IP3 to IP522,23. We also identified Kcs1 as the 
major cryptococcal IP6 kinase, phosphorylating IP6 to the inositol pyrophosphate PP-IP5/IP7, which is crucial 
for cryptococcal virulence23. To identify the intermediary kinase in the pathway, we searched the C. neoformans 
var grubii (strain H99) genomic database (http://www.broadinstitute.org/annotation/genome/cryptococcus_
neoformans/MultiHome.html) for an IP5 kinase homolog using Ipk1 from Saccharomyces cerevisiae as a query. 
CNAG_01294 produced the strongest match and was designated CnIPK1. CnIPK1 is 3245 nucleotides in length 
and is predicted to encode a protein of 415 amino acids. Using the global alignment sequence analysis tool availa-
ble from https://npsa-prabi.ibcp.fr/cgi-bin/npsa_automat.pl?page= /NPSA/npsa_clustalw.html, the CnIpk1 pro-
tein was found to be just 13.7% identical and 26.68% similar to ScIpk1, and 19.18% identical and 28.96% similar 
to human IP5 kinase, inositol-pentakisphosphate 2-kinase. Despite the low homology, a domain search at (http://
pfam.xfam.org/) confirmed the presence of the inositol-pentakisphosphate 2-kinase protein domain (PF06090) 
at the N-terminus of CnIPK1.
Creation of IPK1 deletion mutant strains. To determine whether CnIpk1 is an IP5 kinase that produces IP6, an 
IPK1 deletion mutant (ipk1Δ) and an IPK1 reconstituted strain (ipk1Δ + IPK1) were created in the wild-type 
H99 (WT H99) background using biolistic transformation and homologous recombination as described in the 
methods. KCS1 was also deleted in ipk1Δ to create an ipk1Δ kcs1Δ double mutant. Targeted gene deletion and 
genetic reconstitution were confirmed by PCR and antibiotic resistance testing (see supplementary methods and 
Supplementary Fig. S2).
Comparison of IP profiles of deletion mutants using inositol radiolabelling and HPLC. WT, ipk1Δ, ipk1Δ + IPK1 
and the kcs1Δ strains were radiolabelled with [3H] myo-inositol. The IP profile of lysates prepared from each 
strain was then compared by anion-exchange HPLC (Fig. 1). Similar to many eukaryotic cells including fungi, 
plants and humans, IP6 was found to be the most abundant IP species in the WT cryptococcal strain (Fig. 1A). 
PP-IP5/IP7 and (PP)2-IP4/IP8 were detected in the WT strain, but not in kcs1Δ control strain as reported previ-
ously23. In contrast, IP6, PP-IP5/IP7 and (PP)2-IP4/IP8 were not detected in ipk1Δ, while IP5 and IP4 were increased 
(Fig. 1B). These results are consistent with Ipk1 being the major IP5 kinase in C. neoformans. The reintroduction 
of an intact IPK1 gene into ipk1Δ restored IP5 kinase activity back to the level of the WT strain (Fig. 1C). In addi-
tion to IP4 and IP5, an IP species with an elution time corresponding to PP-IP424 accumulated in the ipk1Δ mutant 
(Fig. 1B) but was absent in the profiles of WT and kcs1Δ (Fig. 1A,D). To determine whether the cryptococcal IP6 
kinase, Kcs1, recognises IP5 as an alternative substrate to IP6 in the ipk1Δ mutant, and converts it to PP-IP4, the 
IP profile of the double ipk1Δ kcs1Δ gene deletion mutant was assessed. We hypothesised that PP-IP4 would not 
be detected in the double mutant if Kcs1 is the progenitor of PP-IP4. The profile of ipk1Δ kcs1Δ (Fig. 1E) confirms 
this prediction and indicates that Kcs1 synthesises the pyrophosphate-containing PP-IP4 using IP5 as substrate. 
However, the absence of PP-IP4 in the WT and kcs1Δ strains, which both have active Ipk1, indicates that Kcs1 acts 
predominantly as an IP6 kinase when Ipk1 is present.
Impact of Ipk1 on stress tolerance and production of virulence traits. We recently demonstrated 
that the PP-IP5/IP7 produced by Kcs1 is crucial for growth of C. neoformans under stress: the kcs1Δ mutant 
exhibited reduced growth in the presence of cell wall perturbing agents, and reduced production of the viru-
lence factors, melanin and urease23. While PP-IP5/IP7 is absent in the kcs1Δ, ipk1Δ and ipk1Δ kcs1Δ mutants, the 
ipk1Δ and ipk1Δ kcs1Δ mutants also fail to produce IP6 (see Table 1 for a summary). We therefore investigated 
whether ipk1Δ and ipk1Δ kcs1Δ exhibit these growth and virulence phenotypes and whether they are attenuated 
to a greater extent than kcs1Δ due to the absence of both IP6 and PP-IP5/IP7. As C. neoformans can replicate 
inside macrophages, tolerance of oxidative and nitrosative stress was also investigated. The results show that the 
kcs1Δ mutant, but not the ipk1Δ mutant, displayed a mild growth defect on rich medium (YPD) at 30 °C and 
37 °C (Fig. 2A). However, the ipk1Δ mutant exhibited a significant growth defect in the presence of two cell wall 
perturbing agents, Congo red and, (even more so), caffeine (Fig. 2B). All mutant strains were mildly sensitive 
to oxidative stress at 37 °C and strongly sensitive to nitrosative stress (Fig. 3). In contrast to our expectation, the 
ipk1Δ growth defect under all of the conditions tested (Figs 2 and 3) was similar to, or mildly better, than that 
observed for the kcs1Δ and ipk1Δ kcs1Δ mutant strains, indicating that loss of IP6 in combination with PP-IP5/IP7 
does not exacerbate the phenotype. Growth of ipk1Δ + IPK1 was similar to WT under all stress conditions tested.
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Production of virulence traits. The kcs1Δ mutant exhibits defects in laccase 1 (Lac1)-induced melanisation: 
in a glucose-deficient environment, expression of the Lac1-encoding gene, LAC1, is repressed in kcs1Δ23. We 
therefore investigated whether the IPK1-deficient mutants displayed a similar phenotype. Since laccase is cell 
wall-associated, extracellular laccase activity was quantified by measuring the oxidation of ABTS by whole cells 
over 120 min following 6 hours of induction in glucose-deficient medium (Fig. 4A). The induction of LAC1 
mRNA after 3 hours induction in glucose-deficient medium was also measured by qRT-PCR (Fig. 4B). Relative 
to WT and ipk1Δ + IPK1, cell-associated laccase activity was reduced in all mutants (Fig. 4A). This reduction in 
ABTS oxidation correlated with reduced LAC1 mRNA expression (Fig. 4B). Similarly, urease production was 
Figure 1. IP profiles of (A) WT, (B) ipk1Δ, (C) ipk1Δ + IPK1, (D) kcs1Δ and (E) ipk1Δ kcs1Δ. Lysates 
prepared from [3H] myo-inositol-labelled cells were subjected to anion-exchange HPLC analysis. IP species 
were eluted using a gradient of increasing phosphate concentration. The elution profile of the IP standards used 
(IP5 isomer [3H]I(1, 3, 4, 5, 6)P5, [3H]IP6, [3H]PP-IP4 and [3H]PP-IP5/IP7) are indicated by the black arrows; grey 
arrows indicate the expected elution profile of I(1, 3, 4, 5)P4 and (PP)2-IP4/IP8 species.
www.nature.com/scientificreports/
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IP5 PP-IP4 IP6 PP-IP5/IP7
WT H99 + − + + 
ipk1Δ + + + + + + − − 
ipk1Δ + IPK1 + − + + 
kcs1Δ + − + − 
ipk1Δ kcs1Δ + + + − − − 
Table 1.  Summary of the IPs and PP-IPs present in the various strains used in this study. + indicates that 
the species is present; + + + indicates accumulation of a species; − indicates absence of a species.
Figure 2. Effect of temperature (A) and cell wall perturbing agents (B) on growth of ipk1Δ, kcs1Δ and 
ipk1Δ kcs1Δ. All strains were serially diluted 10-fold, from 106 cells to 101 cells per 3μL (left to right) and 
dropped onto media containing the reagents indicated. All plates were incubated at 30 °C/37 °C for 72 hours. 
The YPD 30 °C plate was used as a control.
Figure 3. Effect of oxidative and nitrosative stress on growth of ipk1Δ, kcs1Δ and ipk1Δkcs1Δ. All strains 
were serially diluted 10-fold, from 106 cells to 101 cells per 5μL (left to right) and dropped onto YNB + 0.5% 
glucose agar containing the reagents indicated. All plates were incubated at 37 °C for 96 hours.
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reduced in all deletion mutants compared to WT and ipk1Δ + IPK1 as indicated by the diameter of the pink halo 
surrounding the inoculum, following growth on Christensen’s agar (Fig. 5).
IPK mutants are hypersusceptible to antifungal drugs. Since the arg1Δ and kcs1Δ mutants are hypersuscepti-
ble to antifungal drugs23 we investigated the susceptibility of the ipk1Δ and ipk1Δ kcs1Δ mutants to a range of 
clinically-available antifungals, and included kcs1Δ as a control (Supplementary Table S1). Similar to WT and 
kcs1Δ, ipk1Δ and ipk1Δ kcs1Δ retained their resistance to the echinocandins: anidulafundin, micafungin and 
caspofungin. Collectively, the mutants were 2–4 times more sensitive to 5-flucytosine and 4–8 times more sensi-
tive to the azole family (posaconazole, voriconazole, itraconazole and fluconazole). The sensitivity of all mutants 
to amphotericin B was similar to WT.
Growth on alternative carbon sources. Pathogens of the respiratory system including C. neoformans encoun-
ter a low glucose environment during host lung infection9 and cryptococcal metabolic mutants incapable of 
utilising carbon sources other than glucose are attenuated for virulence in animal models25,26. We previously 
demonstrated that the PP-IP5/IP7-deficient kcs1Δ strain is impaired in utilising three non-fermentable carbon 
sources: glycerol, lactate, and oleic acid. We therefore compared the growth of the IPK1-deficient mutant strains 
to that of kcs1Δ when these substrates are used as the sole carbon source (Fig. 6). On the control plate containing 
glucose, all mutant strains grew at a similar rate to that of WT and ipk1Δ + IPK1. However, on plates contain-
ing glycerol, lactate or oleic acid, growth of all of the mutants was reduced. Unlike growth phenotypes in Figs 2 
and 3, growth of kcs1Δ and ipk1Δ kcs1Δ on these alternative carbon sources was more severely attenuated than 
growth of the ipk1Δ mutant. The growth defect seen in kcs1Δ correlated with RNA-seq analysis where expression 
of genes involved in the utilisation of alternative carbon sources was reduced23. We used the same approach to 
compare the gene expression profile of ipk1Δ with those of kcs1Δ and arg1Δ. Arg1 encodes the major IP3 kinase in 
C. neoformans and, like ipk1Δ and kcs1Δ, arg1Δ does not produce PP-IP5/IP7. Figure 7 provides a representative 
summary of the expression of genes associated with glycolysis (Fig. 7A) and the tricarboxylic acid (TCA) cycle 
(Fig. 7B). Glycolysis-related genes in Fig. 7A were similarly up-regulated in arg1Δ, ipk1Δ and kcs1Δ, relative 
to WT. However, although genes encoding TCA cycle enzymes were down-regulated in all mutants, they were 
down-regulated to a lesser extent in ipk1Δ, compared with other mutants (Fig. 7B). The expression of genes 
Figure 4. Effect of IPK gene deletion on extracellular laccase activity (A) and LAC1 gene expression (B). 
Strains were incubated for 3 and 6 hours at 30 °C in minimal media without glucose for gene induction and 
enzyme assay, respectively. (A) ABTS was then added and the amount of oxidised ABTS at each time point was 
measured spectrophotometrically at 436 nm. (B) LAC1 gene expression was determined by qRT-PCR with 
ACT1 used as the reference gene for normalization. A one-way ANOVA multiple comparisons test of all strains 
revealed a statistically significant difference between the 3 mutants and both WT and ipk1Δ + IPK1.  
(****p-value < 0.0001 and error bars represent standard deviation).
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involved in fatty acid β -oxidation and peroxisomal organisation was similarly down-regulated in all mutants 
(Supplementary Fig. S1).
Impact of Ipk1 on cryptococcal virulence in a mouse model. We found previously that the kcs1Δ 
mutant is avirulent in a murine inhalational model of cryptococcosis but establishes a persistent asymptomatic 
infection that remains confined to the lungs for up to 50 days post infection23. Thus, we compared the infec-
tion profile of the IPK deletion mutants using the same model. Mice were inoculated with 5 × 105 CFUs of 
WT, ipk1Δ, ipk1Δ kcs1Δ and ipk1Δ + IPK1, and time to illness (survival) and organ burdens were determined 
(Fig. 8A). The results for kcs1Δ-infected mice were also included in the analysis as a comparison. All WT- and 
ipk1Δ + IPK1-infected mice succumbed to infection over a similar time period (median survival time was 14 and 
19 days, respectively; p = 0.264). However, 80% and 100% of ipk1Δ- and ipk1Δ kcs1Δ-infected mice, respectively, 
survived the infection and maintained their weight and vigour over the 50 day time course. The differences in 
survival between the 3 mutant-infected groups and the WT- and ipk1Δ+IPK1-infected groups was statistically 
significant (p-value < 0.001) as determined by the Kaplan-Meier log rank test.
Lung and brain infection burdens for the WT- and ipk1Δ + IPK1 - infected groups (at time of death) and the 
mutant-infected groups (at time of death or 50 days post-infection for still healthy mice) were also measured 
(Fig. 8B). Lower lung burdens were obtained for all of the mutant strains relative to WT and ipk1Δ + IPK1, with 
ipk1Δ burdens being marginally higher than those of ipk1Δ kcs1Δ and kcs1Δ. However, the reduction observed 
for all mutant strains relative to WT was not statistically significant. Only the PP-IP4-accumulating ipk1Δ mutant 
strain disseminated to the brain. Our results suggest that the accumulated PP-IP4 in ipk1Δ is compensating for 
the absence of PP-IP5/IP7 to partially “restore” cryptococcal load in the lung and permit dissemination. However, 
the improvement is not sufficient to restore virulence. Improved growth of the ipk1Δ mutant strain in lung tissue 
and its ability to disseminate to the brain may be attributable in part to its improved capability to utilise alterative 
carbon sources relative to the other mutants (Fig. 6).
Discussion
We previously described Arg1, Kcs1 and Asp1 as major IP3, IP6 and PP-IP5/IP7 kinases in C. neoformans, respec-
tively. We now report that Ipk1 is the major IP5 kinase in C. neoformans. Deletion of the IPK1 gene (ipk1Δ) 
Figure 5. Effect of IPK gene deletion on urease production 106 cells of each strain was dropped onto 
Christensen’s (urea-containing) agar. All plates were incubated at 30 °C for 72 hours. The extent of urease 
production, which is observed due to the incorporation of the phenol red pH indicator, is proportional to the 
diameter of the pink halo surrounding the inoculum.
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abolished the synthesis of IP6, and the two inositol pyrophosphates, PP-IP5 and (PP)2-IP4, which are produced by 
Kcs1 and Asp1, respectively (Fig. 1B). Since PP-IP5/IP7 is crucial for virulence23 and IP6 is highly abundant, we 
expected that the absence of both IP6 and PP-IP5/IP7 in the ipk1Δ mutant strain would exacerbate the severity of 
the phenotypic defect as compared to kcs1Δ, which is only deficient in PP-IP5/IP7. However, this was not the case, 
since loss of IP6 and PP-IP5/IP7 did not attenuate virulence phenotypes or virulence in animal models to a greater 
extent than the loss of PP-IP5/IP7 alone. Thus, IP6 has a negligible role in fungal physiology and virulence. In 
S. cerevisiae and S. pombe, Ipk1-generated IP6 has an essential role in Gle1p-mediated mRNA export at the 
nuclear pore complex, as mutant strains lacking IPK1 failed to effectively export mRNA from the nucleus27,28. So 
far we have not been able to attribute a role to IP6 in C. neoformans except that it serves as an essential precursor 
for the synthesis of PP-IP5/IP7.
It remains to be determined how PP-IP5 exerts its effect in C. neoformans. The pleiotropic phenotype of kcs1Δ 
and its transcriptional profile indicate that PP-IP5 markedly affects gene expression29–32. PP-IP5/IP7 might regulate 
gene expression by interacting directly with components of the transcription regulatory complexes/chromatin 
remodelling machinery, or by pyrophosphorylating transcriptional regulators to alter their activity33,34.
PP-IP4 accumulated in the ipk1Δ mutant, but its production was abolished following co-deletion of KCS1 
and IPK1. Similar to Kcs1 in S. cerevisiae24,35, our results demonstrate that cryptococcal Kcs1 is the progenitor of 
PP-IP4 when Ipk1 is absent. However, when Ipk1 is present, as in the case of WT and the kcs1Δ mutant, PP-IP4 is 
not produced, indicating that Kcs1 acts predominantly as an IP6 kinase. Thus, cryptococcal Kcs1 is a dual spec-
ificity kinase acting primarily as an IP6 kinase to produce PP-IP5, and as an IP5 kinase producing PP-IP4 when 
IP6 is unavailable. However, the physiological significance of PP-IP4 production remains to be determined. The 
predominant roles of Ipk1 and Kcs1 in vivo are most likely related to their relative affinities for IP5 and IP6 and the 
greater abundance of IP6. A model of the complete IP biosynthesis pathway in C. neoformans depicting the role of 
Ipk1 and the new role for Kcs1 is shown in Fig. 9.
None of the mutants in this study (ipk1Δ, kcs1Δ, ipk1Δ kcs1Δ) generate PP-IP5/IP7. However, a comparison 
of the ipk1Δ and kcs1Δ phenotypes revealed that the ipk1Δ phenotype is more robust than the kcs1Δ and ipk1Δ 
kcs1Δ phenotypes, particularly in the case of virulence in mice. Although Ipk1 was crucial for virulence, with only 
20% of the ipk1Δ-infected mice succumbing to infection over a 50 day infection period, no deaths were recorded 
in the kcs1Δ - or ipk1Δ kcs1Δ-infected groups over the same time period. Furthermore, there was a trend towards 
ipk1Δ producing higher burdens of infection in the lungs and being the only mutant with an ability to disseminate 
Figure 6. Effect of IPK1 deletion on alternative carbon source utilisation. All strains were serially-diluted 
10-fold, from 106 cells to 101 cells per 3 μL (left to right) and dropped onto minimal media (MM) containing 
the carbon sources indicated. MM + 1% glucose was used as a control. All plates were incubated at 30 °C for 
72 hours.
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to the brain despite a similar reduction in urease as compared to the other mutants. Urease has been implicated 
as a factor enabling C. neoformans to cause meningoencephalitis5.
Nutritional availability in the host lung, glucose in particular, is limited and it is imperative for microbial path-
ogens to adapt their metabolism accordingly. In agreement with its improved proliferation in the host lung, as 
compared to Kcs1-deficient mutants, ipk1Δ was able to metabolise glycerol, lactate and oleic acid more efficiently 
and grew significantly better than the other mutants in the presence of these compounds as a sole carbon source. 
Glycerol, lactate and the unsaturated fatty acid, oleic acid, are incorporated into the tricarboxylic acid (TCA) cycle 
via different routes. Glycerol is converted to glyceraldehyde 3-phosphate, lactate is oxidised to pyruvate, and oleic 
acid undergoes β -oxidation to produce acetyl-CoA. Our RNA-seq data demonstrate that genes encoding TCA 
cycle enzymes are down-regulated in arg1Δ, ipk1Δ and kcs1Δ mutants. However, this down-regulation is less 
pronounced in ipk1Δ than in arg1Δ and kcs1Δ (Fig. 7B).
A possible explanation for the more robust ipk1Δ phenotype (improved metabolism of alternative carbon 
sources and, to a lesser extent, growth on rich medium) is that PP-IP4 can (partially) compensate for the absence 
of PP-IP5/IP7 by fulfilling some of its functions. This is supported by the fact that PP-IP4 and PP-IP5/IP7 are 
structurally similar (see Fig. 9). Both pyrophosphates have a diphosphate at the 5′ position on the inositol ring. 
The difference between the two species is the absence of a phosphate group at the 2′ position in PP-IP4, which 
is replaced by a hydroxyl group. A similar compensation phenomenon was demonstrated in S. cerevisiae, where 
in the absence of other inositol pyrophosphates, PP-IP4 is sufficient to regulate endocytic trafficking and ensure 
normal vesicular morphology35. Due to the minor structural difference, PP-IP4 may be able to bind to and/or 
Figure 7. Expression of glycolysis (A) and TCA cycle (B) associated genes in arg1Δ, ipk1Δ and kcs1Δ 
mutants, relative to WT H99.Wild type and mutant cultures grown overnight in YPD broth were used for RNA 
extraction, followed by RNA-seq gene expression analysis (green, down-regulated expression; red, up-regulated 
expression). The colour bar to the left of each heat map demonstrates the log2 fold changes from comparison of 
each mutant to WT.
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pyrophosphorylate some, but not all, of the PP-IP5/IP7 targets. The relative stability of the terminal phosphate 
on the diphosphate of PP-IP4 and its ability to pyrophosphorylate pre-phosphorylated proteins remains to be 
investigated. Cryptococcal phenotypes uniquely dependent on PP-IP5/IP7 include cell wall integrity, oxidative/
nitrosative stress tolerance, and laccase and urease production.
C. neoformans encounters oxidative and nitrosative stress initiated by macrophages during infection. IPs have 
been reported to act as antioxidants, with IP6 being the most potent36,37. Hawkins et al.37 determined that the iron 
(Fe3+)-chelating properties of IP6 could prevent the formation of toxic reactive oxygen species (ROS). Since iron is 
also involved in catalysing the production of reactive nitrogen species (RNS)38, we assessed the ability of the IPK 
mutant strains to tolerate oxidative and nitrosative stress by adding hydrogen peroxide (H2O2) and sodium nitrite 
(NaNO2), respectively, to the YNB growth medium. However, the growth rates of IP6-deficient ipk1Δ and ipk1Δ 
Figure 8. Effect of IPK deletion on virulence in a murine inhalation model of cryptococcosis. (A) Survival 
analysis. Isoflurane-anaesthetised mice were inoculated intranasally with 5 × 105 CFUs of WT, ipk1Δ, kcs1Δ, 
ipk1Δ kcs1Δ and ipk1Δ+IPK1, and euthanised after showing debilitating symptoms of infection, or at 50 days 
post-infection for asymptomatic mice (see Methods). A survival analysis (Kaplan-Meier log rank test) revealed 
statistically significant differences in survival between the mutant groups and both WT and ipk1Δ+IPK1 
(p < 0.001). Median survival of mice infected with WT H99 and ipk1Δ+IPK1 was 14 and 19 days, respectively, 
but the difference was not statistically significant (p > 0.05). Note that similar to kcs1Δ-infected mice23 all 
ipk1Δ kcs1Δ-infected mice were healthy with no sign of illness or weight loss for up to at least 50 days post-
infection. (B) Organ burden analysis. Infection burdens were determined at time of death or upon termination 
of the experiment (Day 50). For each strain, organs were harvested from 3 mice. Results represent the mean 
logCFUs ± SEM. The PP-IP4-deficient strains, kcs1Δ and ipk1Δ kcs1Δ, did not disseminate to the brain.
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kcs1Δ strains and the IP6-producing kcs1Δ strain were similar in the presence of either reagent (Fig. 3) suggesting 
that the absence of IP6 is not the crucial factor contributing to the oxidative/nitrosative stress sensitivity of ipk1Δ.
Unlike in mammalian cells, IPK enzymes in C. neoformans are not redundant and share a low sequence sim-
ilarity with their mammalian equivalents. Cryptococcal IPK enzymes therefore represent targets for antifungal 
drug design. CnIpk1 is only 19.18% identical to the mammalian homolog inositol-pentakisphosphate 2-kinase. 
CnKcs1 is 12.65%, 11.69% and 12.09% similar to its three equivalent mammalian kinases, inositol hexakisphos-
phate kinase 1 isoform 1 (IP6K1), IP6K2 and IP6K3, respectively. Mutant strains lacking KCS1 and IPK1 showed 
increased susceptibility to the azole family of drugs (Supplementary Table S1). This suggests that inhibitors 
directed against these enzymes, especially Kcs1 due to its crucial role in PP-IP5/IP7 production, could potentially 
act synergistically with azoles and improve treatment outcome. Furthermore, IP kinases with low homology to 
mammalian enzymes are also found in other medically important opportunistic fungal pathogens, including 
Candida albicans, potentially extending the applicability of IPK inhibitors to other fungal pathogens.
Conclusion
Using gene deletion analysis we have identified Ipk1 as the major IP5 kinase in C. neoformans and as a major 
contributor to cryptococcal pathogenicity. However, the means by which Ipk1 contributes to pathogenicity is due 
to its indirect role in the production of PP-IP5/IP7, rather than its direct role in producing IP6. Our results using 
double deletion mutants show that the contribution of IP6 to pathogenicity is, in fact, relatively insignificant and 
confirm our previous observation that PP-IP5/IP7 is the most crucial IP species. We have also demonstrated an 
additional kinase activity for Kcs1, which is only evident when Ipk1 is absent. This activity involves production 
of an additional inositol pyrophosphate species, PP-IP4. In ipk1Δ, PP-IP4 function may overlap with PP-IP5/IP7 to 
partially restore utilisation of alternative carbon sources, lung infection burdens and dissemination to the CNS, 
even though ipk1Δ infection remains predominantly asymptomatic.
Methods
Fungal strains and media. Strains used in this study were wild-type C. neoformans var. grubii strain H99 
(serotype A, MATα) and ipk1Δ, kcs1Δ, ipk1Δ kcs1Δ and reconstituted ipk1Δ (ipk1Δ + IPK1) which were all cre-
ated from WT H99. Strains were routinely grown on YPD (1% yeast extract, 2% peptone and 2% dextrose) or 
Sabouraud (SAB) agar (1% peptone, 4% glucose, 1.5–2% agar). Urease production was assessed on Christensen’s 
urea agar (2% urea, 1.5% agar, 0.08% NaH2PO4.H2O, 0.12% Na2HPO4, 0.1% peptone, 0.1% glucose, 0.5% NaCl, 
0.0012% phenol red, pH 6.8). Plates were incubated at 30 °C for 72 hours.
Creating transgenic strains. The IPK1 gene deletion construct was made using overlap PCR to join the 5′ 
flanking region, the neomycin resistance cassette (NEOR) and the 3′ flanking region. The flanking regions were 
amplified from WT H99 genomic DNA and NEOR from plasmid pJAF1 (a gift from Dr John R Perfect, Duke 
University, Durham, NC, USA)39. The deletion construct, which effectively had NEOR in place of the IPK1 coding 
region, was then transformed into the WT H99 strain using biolistic transformation40. Successful transformants 
(ipk1Δ::NEO) whereby the NEOR had replaced the IPK1 gene by homologous recombination, were selected on 
YPD agar plates containing 0.5M sorbitol and 100μL/mL geneticin (G418).
To construct the reconstituted strain, ipk1Δ + IPK1, the IPK1 gene (with 973 bp of 5′ flank and 622 bp of 3′ 
flank) was amplified from WT H99 genomic DNA. The hygromycin BR cassette was also amplified by PCR. The two 
fragments were fused together using overlap PCR. The final fragment was then transformed into the ipk1Δ strain 
Figure 9. The inositol polyphosphate biosynthesis pathway in C. neoformans. Plc1 – produced IP3 is 
sequentially phosphorylated to IP4, IP5 and IP6 by Arg1 and Ipk1. Kcs1 generates PP-IP4 and PP-IP5/IP7 from 
IP5 and IP6, respectively. (PP)2-IP4 is derived from Asp1. The Inset represents the position of the phosphates on 
the inositol ring. Figure was adapted from23.
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by biolistic transformation. Transformants were selected on YPD agar containing 0.5M sorbitol and 350 μL/mL 
hygromycin B. To create the double gene deletion mutant, ipk1Δ kcs1Δ, we created a KCS1 deletion cassette, 
kcs1Δ::NAT, using PCR, which was introduced into the ipk1Δ strain using biolistic transformation to disrupt 
KCS1. Successful transformants were selected on YPD agar containing 0.5M sorbitol and 100μg/mL nourseo-
thricin. kcs1Δ::NEO was previously created as described in ref. 23.
[3H]-inositol labelling of inositol poly- (IP) and pyrophosphates (PP-IP). The protocol used for 
[3H]-inositol labelling of the cryptococcal strains was adapted from41. Overnight YPD cultures of WT, ipk1Δ, 
kcs1Δ, ipk1Δ kcs1Δ and ipk1Δ + IPK1 were diluted to OD600 = 0.05 in 5 mL YPD containing 10μCi/mL [3H] 
myo-inositol (PerkinElmer) and incubated with shaking at 200 rpm at 30 °C until the culture OD600 reached 
at least 12.8 (18–35 hrs). The cells were pelleted by centrifugation (maximum speed for 10 minutes at 4 °C), 
washed twice with 1 mL ice-cold YPD and snap-frozen in liquid nitrogen. To extract IP/PP-IPs, the cell pellets 
were resuspended in extraction buffer (1M HClO4, 3mM EDTA, 0.1 mg/mL IP6) and homogenised at 4 °C with 
a MiniBeadbeater-8 cell disrupter (Daintree Scientific, TAS, Australia): 4 × 30 second cycles with 1 minute rest 
on ice in between cycles. The debris was pelleted by centrifugation (maximum speed for 5 minutes at 4 °C). The 
pH of IP extracts was neutralised by titration with neutralisation buffer (1M K2CO3, 3mM EDTA). Samples were 
then incubated on ice for 2 hours, centrifuged at maximum speed for 10 minutes at 4 °C, and supernatants were 
collected for anion-exchange HPLC as described in41. IP/PP-IP species were identified using the relevant stand-
ards. Specifically: 3H-IP6 was acquired from (PerkinElmer NEN (New England Nuclear)); 3H-I(1, 3, 4, 5, 6)P5 was 
prepared using IPMK as previously described42; PP-IP5/IP7 was prepared using IP6K1 as previously described43. 
All the radiolabeled inositol phosphates in vitro synthesized were HPLC purified and desalted as described44. 
PP-IP4 was purified from 3H-inositol radiolabelled Saccharomyces cerevisiae ipk1Δ strain35.
Quantification of laccase activity and LAC1 gene expression. Laccase activity.  The assay for quan-
tifying extracellular laccase activity was adapted from23 and is based on the oxidation of the laccase substrate, 
2, 2′ -Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS). All strains were adjusted to OD600 = 1 and 
induced in minimal media without glucose (10μM CuSO4, 10 mM MgSO4, 29.4 mM KH2PO4, 13 mM glycine and 
3μM thiamine) for 6 hours at 30 °C. Following induction, an assay mixture consisting of cells, distilled H2O and 
3mM ABTS was incubated at 30 °C over a 120 minute time course, with absorbance readings taken at 15, 30, 60, 
90 and 120 mins. At each time point, cells were pelleted by centrifugation, and the absorbance of the supernatant 
at 436 nm was measured using a spectrophotometer.
LAC1 gene expression was measured using SYBR Green qRT-PCR (Corbett Rotor-Gene 6000) with mRNA 
extracted from cells after a 3 hour induction in minimal media without glucose. ACT1 was used as a reference 
gene. Relative quantification was determined using the ΔΔCt method45.
Spot dilution assays. WT, ipk1Δ, kcs1Δ, ipk1Δ kcs1Δ and ipk1Δ + IPK1 strains were cultured overnight in 
YPD broth, serially diluted 10-fold and spotted onto the following medium: YPD agar containing 0.5 mg/mL caf-
feine or 0.5% Congo red to examine the effect of these cell-wall perturbing agents on growth; minimal media agar 
supplemented with 1% glucose, 1% glycerol, 1% sodium lactate or 1% oleic acid as the sole carbon source to assess 
carbon source utilisation; and YNB (pH 4) + 0.5% glucose agar with or without 1mM H2O2/NaNO2 to determine 
the effect of oxidative/nitrosative stress. Plates were incubated at 30 °C/37 °C for 72–96 hours.
RNA-seq. The methodology pertaining to RNA-seq is described in23. The following equation was used to 
generate expression values for heat maps: log2(FPKMmutant/FPKMWT). Clustering was performed using Gene 
Cluster 3 (University of Tokyo, Human Genome Center http://bonsai.hgc.jp/~mdehoon/software/cluster/soft-
ware.htm#ctv) and the heat maps drawn using Java TreeView (http://jtreeview.sourceforge.net/). Expression data 
used to generate the heat maps are listed in Supplementary spreadsheet 1. The whole RNA-seq dataset has been 
deposited in the NCBI GEO database under the accession number GSE78824.
Murine inhalation model of cryptococcosis. All procedures described were approved and governed 
by the Sydney West Local Health District Animal Ethics Committee, Department of Animal Care, Westmead 
Hospital, and all procedures were carried out in accordance with the guidelines and regulations of this institute. 
Survival and organ burden were conducted using 7-week-old female BALB/c mice obtained from the Animal 
Resource Centre, Floreat Park, Western Australia. Mice were anaesthetised using isoflurane (in oxygen) delivered 
via an isoflurane vapouriser attached to a Stinger Small Animal Anaesthetic Machine (Advanced Anaesthesia 
Specialists).
Groups of 10 mice were inoculated intranasally with WT, ipk1Δ, kcs1Δ, ipk1Δ kcs1Δ and ipk1Δ + IPK1 strains 
(5 × 105 cells/20μl PBS). Viable yeast cells inoculated into the nares were quantified following culture on SAB 
plates. Mice were observed daily for 50 days for signs of ill-health. Mice were deemed to have succumbed to 
infection if they had lost 20% of their pre-infection weight and/or if they showed debilitating clinical signs such 
as respiratory distress, hunching, excessive ruffling and reduced mobility. Sick mice were euthanised by CO2 
inhalation followed by cervical dislocation. Lungs and brain were removed from 3 mice and assessed for infection 
burden following homogenisation and quantitative culture as previously described23. All healthy mice were also 
euthanised as above at the end of the study, 50 days post-inoculation, and organ burdens were quantified as above. 
Differences in survival were analysed with SPSS (Version 20) statistical software, using the Kaplan-Meier method 
(Mantel-Cox log-rank test), where a p-value < 0.001 was considered statistically significant.
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